Work

Successful treatment of murine β-thalassemia using in vivo selection of genetically modified, drug-resistant hematopoietic stem cells

Year: 2003

Type: article

Source: Blood

DOI: 10.1182/blood-2003-03-0677

Authors: Derek A. Persons, Esther R. Allay, Nobukuni Sawai, Phillip W. Hargrove, Thomas P. Brent, Hideki Hanawa, Arthur W. Nienhuis, Brian P. Sorrentino

Institution: St. Jude Children's Research Hospital

Language: English

Topic: Virus-based gene therapy research

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Heart, Lung, and Blood Institute, National Cancer Institute

Awards: Lentiviral Gene Therapy for Sickle Cell Disease And Immunodeficiency Disorders, GAMMA GLOBIN VECTORS FOR TREATMENT OF HEMOGLOBINOPATHIES, G609150708, Cancer Center Support Grant (CCSG)

OpenAlex ID: W2032487385

FWCI: 6.754

Cites: 40

Cited by: 125

Related to: 9